Your browser doesn't support javascript.
loading
What Is the Optimal Follow-up Time to Ascertain the Safety of Proton Pump Inhibitors?
Losurdo, Giuseppe; Di Leo, Alfredo; Leandro, Gioacchino.
Affiliation
  • Losurdo G; Section of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Italy.
  • Di Leo A; Section of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Italy.
  • Leandro G; Gastroenterology Unit, National Institute of Gastroenterology, "S. De Bellis" Research Hospital, Castellana Grotte, Italy.
Gastroenterology ; 158(4): 1175, 2020 03.
Article in En | MEDLINE | ID: mdl-31884072
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proton Pump Inhibitors / Rivaroxaban Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Gastroenterology Year: 2020 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proton Pump Inhibitors / Rivaroxaban Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Gastroenterology Year: 2020 Type: Article Affiliation country: Italy